Robert M. Rifkin, M.D., F.A.C.P.

Biography

Positions:

  • Founder of Rocky Mountain Blood and Marrow Transplant Program, 2003
  • Clinical Associate Professor of Medicine, Department of Internal Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Denver, Colorado
  • Inspector, Foundation for Accreditation of Cellular Therapy
  • Member, Executive Board of Directors, National Patient Advocate Foundation
  • Colorado State Chair, National Patient Advocate Foundation
  • Medical Director of Biosimilars, McKesson Specialty Health, US Oncology Research
  • Medical Director of Stem Cell Transplant Research, US Oncology Research

Specialties

Blood and Marrow Transplantation, Coagulation Problems, Blood Banking and Apheresis. Medical Oncology and Hematology.

Interests

I stress continuity of care and access to state-of-the-art therapies and treatments. It’s essential to rapidly develop therapies and provide them to patients.

Education & Background

Undergraduate: Bachelor of Arts, Colorado College, Colorado Springs, Colorado

Medical school: Doctor of Medicine, University of Colorado School of Medicine, Denver, Colorado; categorical internal medicine intern- University of Colorado Hospitals, Denver, Colorado; research associate, Division of Medical Oncology, University of Colorado Health Science Center, Denver, Colorado; categorical internal medicine intern, Presbyterian/St. Luke’s Medical Center, Denver, Colorado; internal medicine resident, Presbyterian/St. Luke’s Medical Center, Denver, Colorado; medical oncology/hematology fellowship, University of Arizona Health Sciences Center, Tucson, Arizona

Other

Board Certifications: American Board of Internal Medicine, board certified in internal medicine, board certified in medical oncology, board certified in hematology.

Honorary Designations: Fellow of the American College of Physicians.

Awards: Trailblazer Award – National Marrow Donor Program, 1998; Top Doctors in Denver – 5280 Magazine, 2000 and 2004; Leukemia and Lymphoma Society – Man of the Year (Colorado), 2001, America’s Top Physicians, 2005.

Clinical Research: Focus on new treatments and therapies in multi myeloma and those that help make transplant less toxic. Supportive care for patients and drug development. Research efforts have been highlighted in over 60 publications.

  • Locations
  • Doctors
  • Conditions